CarelonRx Segment — Operating revenue - total
Elevance Health CarelonRx Segment — Operating revenue - total decreased by 9.0% to $10.60B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.8%, from $10.12B to $10.60B. Over 4 years (FY 2021 to FY 2025), CarelonRx Segment — Operating revenue - total shows an upward trend with a 14.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Rising revenue indicates successful expansion of pharmacy services and increased service utilization, whereas declining revenue may signal loss of contracts or reduced pharmacy spend.
Detailed definition
The aggregate revenue recognized by the CarelonRx segment from all sources, including pharmacy services, administrative...
Peer comparison
Comparable to total segment revenue for PBM divisions at diversified healthcare companies.
elv_segment_carelonrx_operating_revenue_totalHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.36B | $6.36B | $6.36B | $6.68B | $7.07B | $7.25B | $7.52B | $8.02B | $8.47B | $8.52B | $8.83B | $8.07B | $8.77B | $9.14B | $9.98B | $10.12B | $10.64B | $11.00B | $11.64B | $10.60B |
| QoQ Change | — | +0.0% | +0.0% | +5.1% | +5.8% | +2.5% | +3.8% | +6.7% | +5.5% | +0.6% | +3.6% | -8.6% | +8.8% | +4.2% | +9.1% | +1.4% | +5.2% | +3.3% | +5.9% | -9.0% |
| YoY Change | — | — | — | — | +11.2% | +14.0% | +18.3% | +20.1% | +19.7% | +17.5% | +17.3% | +0.5% | +3.6% | +7.3% | +13.0% | +25.4% | +21.3% | +20.3% | +16.7% | +4.8% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Elevance Health's carelonrx segment — operating revenue - total?
- Elevance Health (ELV) reported carelonrx segment — operating revenue - total of $10.60B in Q1 2026.
- How has Elevance Health's carelonrx segment — operating revenue - total changed year-over-year?
- Elevance Health's carelonrx segment — operating revenue - total increased by 4.8% year-over-year, from $10.12B to $10.60B.
- What is the long-term trend for Elevance Health's carelonrx segment — operating revenue - total?
- Over 4 years (2021 to 2025), Elevance Health's carelonrx segment — operating revenue - total has grown at a 14.3% compound annual growth rate (CAGR), from $25.43B to $43.40B.
- What does carelonrx segment — operating revenue - total mean?
- The total revenue generated by the CarelonRx pharmacy services business segment.